Pharma news
Americas
AstraZeneca has sued the US Food and Drug Administration, asking a court to prevent the FDA from approving any generic version of Crestor, which is due to expire on July 8 this year. 30 June 2016
Americas
The Biotechnology Innovation Organisation has welcomed Hillary Clinton’s plans to improve the US’s patent system. 30 June 2016
Pharma
The UK’s vote to leave the EU has triggered an immediate need for innovative life sciences companies to evaluate the impact on their patent strategies, argues Laetitia Benard of Allen & Overy. 30 June 2016
Americas
BTG International and Janssen have sued Glenmark Pharmaceuticals claiming it has infringed a patent covering the Zytiga drug. 29 June 2016
Pharma
Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses. 28 June 2016
Pharma
The European Patent Office has said that it expects a solution will be found to allow the implementation of the unitary patent despite the referendum result. 24 June 2016
Americas
Teva has settled its patent litigation dispute with AstraZeneca centring on diabetes drug Byetta. 24 June 2016
Pharma
The practicalities of litigating disputes were discussed yesterday in the session “Collaboration agreements – What are the best jurisdictions to resolve disputes” at the Life Sciences Law Forum 2016 in London. 24 June 2016
Pharma
After the “EU Summary of Clinical Trial Results for Laypersons” was published for consultation in June, a counsel from Novo Nordisk discussed the importance of providing reliable information for patients at an industry event in London. 23 June 2016
Pharma
While pharmaceutical companies are more likely to seek patent protection for their inventions, trade secrets can be useful too, particularly following two recent legislative developments, say Andy Sanderson and Ling Zhuang of Potter Clarkson. 23 June 2016